. 2020 Oct;32(10):674–684. doi: 10.1016/j.clon.2020.05.003

Table 4.

Palliative radiotherapy guidelines from The Royal College of Radiologists (RCR) and American Society for Radiation Oncology (ASTRO)

RCR guidance [14]
Good performance^∗ NSCLC patients	20 Gy/5 fractions over 1 week or
	30 Gy/10 fractions over 2 weeks or
	36 Gy/12 fractions over 2.5 weeks or
	39 Gy/13 fractions over 2.5 weeks
Poor performance status^∗ NSCLC patients	17 Gy/2 fractions over 8 days or
Poor performance status^∗ NSCLC patients	10 Gy/1 fraction
Metastatic SCLC patients^†	30 Gy/10 fractions
ASTRO guidance [15]
Performances status 0–2, stage III NSCLC and life expectancy of >3 months patients	30 Gy/10 fractions to 42 Gy/14 fractions + concurrent chemotherapy
Good performance status^∗ NSCLC patients	30 Gy/10 fractions or more
Poor performance status^∗ NSCLC patients	20 Gy/5 fractions or 17 Gy/2 fractions or 10 Gy/1 fraction

NSCLC, non-small cell lung cancer; SCLC, small cell lung cancer.

^∗

Good and poor performance status undefined.

^†

Patients who respond well to primary chemotherapy but who have persistent intrathoracic disease/symptoms.